Peptide Purity Testing and Certificate of Analysis Interpretation

A Certificate of Analysis (COA) is the primary quality document accompanying a research peptide shipment. It provides analytical evidence that the compound matches its stated identity and meets the claimed purity specification. This guide explains what a well-prepared COA contains, how to interpret the key analytical results, and what absent or anomalous findings may indicate about a supplier's quality programme. All content is provided for laboratory and research reference purposes only.

Why the COA Is the Foundation of Peptide Quality Assurance

Peptide purity matters for experimental reproducibility. An impure compound introduces additional molecular species — truncated sequences, deletion products, oxidation byproducts — that may interact with biological systems in unpredictable ways. SafePeptides.net provides lot-specific COAs with every order. Our COA testing standards page explains the analytical workflow applied to each batch.

What a Complete COA Contains

• Product name and common synonyms
• Peptide sequence (one-letter or three-letter amino acid code)
• Molecular formula and exact molecular weight
• CAS number (where applicable)
• Lot or batch number
• Manufacture date and expiry date
• HPLC purity result (% and chromatogram)
• Mass spectrometry result (observed vs. expected molecular weight)
• Counterion and net peptide content
• Recommended storage conditions
• Name and details of the testing laboratory

Understanding HPLC Purity

HPLC purity is expressed as the percentage of total chromatographic area attributable to the main peptide peak at a defined wavelength — typically 214 nm. A result of ≥99% means 99% or more of the UV-absorbing material co-elutes with the target peptide. Research-grade compounds should specify ≥95% minimum; high-quality research grade ≥99%.

Mass Spectrometry: Confirming Peptide Identity

HPLC purity alone cannot confirm the correct sequence is present. Mass spectrometry measures the mass-to-charge ratio and provides molecular weight data comparable against the theoretical mass of the correct sequence. Confirmed charge states ([M+H]⁺, [M+2H]²⁺) within instrument tolerance confirm the correct sequence is present.

Net Peptide Content and Counterion Considerations

Net peptide content accounts for non-peptide components (water, counterion, residual solvents) and represents the true mass fraction of the bioactive peptide sequence. When preparing solutions of defined concentration, net peptide content should be used to calculate accurate weights. Trifluoroacetate (TFA) — a common counterion — can be cytotoxic at elevated concentrations in cell-based assays.

Endotoxin Testing

For in vitro cell culture and animal model work, endotoxin contamination can induce inflammatory responses that confound experimental results. COAs for endotoxin-tested lots state the result in EU/mg. For general cell culture research, ≤1 EU/mg is typical.

Red Flags in Supplier COA Documentation

• Generic or stock COAs — no batch number, no date, no instrument details
• Missing mass spectrometry data — HPLC alone cannot confirm identity
• Chromatograms with unlabelled axes
• Purity figures inconsistent with visible chromatogram
• No testing laboratory identification
• Identical COAs across multiple products or lots

Third-Party vs. In-House Testing

SafePeptides.net works with independent analytical testing partners; details are available on the COA testing page. For questions about interpreting a COA, visit our FAQ page or contact our team.

Key Takeaways

• A complete COA contains lot-specific HPLC and MS data, batch number, date, and testing laboratory details.
• HPLC purity confirms a single dominant compound; MS confirms it is the correct compound.
• Net peptide content — not raw HPLC purity — should be used when preparing concentration-defined solutions.
• Absent or generic COA documentation is a significant quality risk indicator.